Refine
Has Fulltext
- yes (7)
Is part of the Bibliography
- yes (7)
Document Type
- Journal article (7)
Language
- English (7)
Keywords
- apoptosis (5)
- TRAIL (4)
- CD95 (3)
- NFkB (2)
- TNF (2)
- multiple myeloma (2)
- Activation (1)
- Apoptosis (1)
- BH3-only proteins (1)
- CASPASE-3 (1)
- CD27 (1)
- CD40 (1)
- CD70 (1)
- Expression (1)
- FAS (1)
- Factor receptor (1)
- Factor-alpha (1)
- HaCaT cells (1)
- Inhibitor (1)
- MCL-1 (1)
- Medizin (1)
- NF-Kappa-B (1)
- Nekrose (1)
- Polymorphisms (1)
- Promoter (1)
- Transcription (1)
- Tumor-necrosis-factor (1)
- activation (1)
- aryl hydrocarbon receptor (AhR) (1)
- benzo[a]pyrene (1)
- carcinoma (1)
- cell death (1)
- degradation (1)
- dendritic cells (1)
- dermatitis (1)
- growth-factor receptor (1)
- human keratinocytes (1)
- inhibitor (1)
- ligand trail (1)
- mediated apoptosis (1)
- mitochondrial dysfunction (1)
- pathways (1)
- progression (1)
- resistance (1)
- scFv (1)
- skin (1)
- trail-mediated apoptosis (1)
In this study, we have analysed the apoptotic effects of the ubiquitous environmental toxin benzo[ a] pyrene (BP) in HaCaT cells and human keratinocytes. Although prolonged exposure to BP was not cytotoxic on its own, a strong enhancement of CD95 (Fas)-mediated apoptosis was observed with BP at concentrations activating the aryl hydrocarbon receptor (AhR). Importantly, the ultimately mutagenic BP-metabolite, that is, (+)-anti-BP-7,8-diol-9,10-epoxide (BPDE), failed to enhance CD95-mediated cell death, suggesting that the observed pro-apoptotic effect of BP is neither associated with DNA adducts nor DNA-damage related signalling. CD95-induced apoptosis was also enhanced by beta-naphtoflavone, a well-known agonist of the AhR that does not induce DNA damage, thus suggesting a crucial role for AhR activation. Consistently, BP failed to sensitise for CD95L-induced apoptosis in AhR knockdown HaCaT cells. Furthermore, inhibition of CYP1A1 and/or 1B1 expression did not affect the pro-apoptotic crosstalk. Exposure to BP did not increase expression of CD95, but led to augmented activation of caspase-8. Enhancement of apoptosis was also observed with the TRAIL death receptors that activate caspase-8 and apoptosis by similar mechanisms as CD95. Together, these observations indicate an interference of AhR signalling with the activity of receptor-associated signalling intermediates that are shared by CD95 and TRAIL receptors. Our data thus suggest that AhR agonists can enhance cytokine-mediated adversity upon dermal exposure.